Collaborating to Meet The Challenge of Air Cargo Cold Chain Regulations

The number of temperature-sensitive pharmaceutical products is growing, as is the worldwide demand for these highly sensitive goods. Patients in developing as well as emerging markets rely on the fast, safe delivery of life-saving drugs and vaccines, and this is driving an ever-more valuable market for cold chain logistics, estimated to reach $9.3 billion by 2017, according to the Biopharma Cold Chain Sourcebook. Advances in technology, packaging, and supply chain management allow temperature-s... To continue reading this story Click Here